- Maternal serum thromboxane B2 concentrations do not predict improved outcomes in high-risk pregnancies in a low-dose aspirin trial. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medical Units. Hauth, J., Sibai, B., Caritis, S., VanDorsten, P., Lindheimer, M., Klebanoff, M., MacPherson, C., Landon, M., Paul, R., Miodovnik, M., Meis, P., Dombrowski, M., Thurnau, G., Walsh, S., McNellis, D., Roberts, J.M. Am. J. Obstet. Gynecol. (1998)